Skip to main content
Universe Pharmaceuticals INC (UPC)
NASDAQ: UPC · Real-Time Price · USD
0.294
-0.047 (-13.83%)
Sep 20, 2024, 4:00 PM EDT - Market closed

UPC Revenue

In the fiscal year ending September 30, 2023, Universe Pharmaceuticals INC had annual revenue of $32.31M, down -19.52%. Universe Pharmaceuticals INC had revenue of $13.84M in the half year ending September 30, 2023, a decrease of -41.57%.

Revenue (ttm)
$32.31M
Revenue Growth
-19.52%
P/S Ratio
0.04
Revenue / Employee
$143,594
Employees
225
Market Cap
6.95M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Sep 30, 202332.31M-7.83M-19.52%
Sep 30, 202240.14M-7.84M-16.34%
Sep 30, 202147.98M17.28M56.27%
Sep 30, 202030.70M-2.53M-7.60%
Sep 30, 201933.23M4.72M16.54%
Sep 30, 2018 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
CareMax 784.55M
Pulmatrix 11.39M
Syra Health 7.07M
Addex Therapeutics 1.53M
TFF Pharmaceuticals 1.20M
Bionomics 451.25K
Vaccinex 356.00K
ABVC BioPharma 136.40K
Revenue Rankings

UPC News

More News